Biogen Inc
NASDAQ: BIIB
$145.53
+$3.04 (+2.1%)
Closing Price on February 5, 2025
BIIB Articles
Sometimes, stocks that are perceived as growth stocks slip into value metrics, and that can lead to some big gains for investors. Four quality stock picks from Jefferies have those characteristics...
Published:
The Friday afternoon analyst calls were focused on Biogen, Fortinet, Pinterest, Snap and more.
Published:
Last Updated:
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published:
The Friday afternoon analyst calls were focused on Biogen, 3D Systems, Duke Energy, Ford, and more.
Published:
Tuesday's midday analyst calls included Peloton Interactive, Biogen, Square and Lockheed Martin.
Published:
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
These four top stocks offer investors with a longer time horizon solid value and outstanding entry points. They are outstanding ideas for those looking to leave pricier growth companies but wanting...
Published:
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon, Square and Wayfair.
Published:
Last Updated:
24/7 Wall St. has tracked multiple analyst calls regarding the expected approval or nonapproval of aducanumab as the first viable treatment against Alzheimer's disease.
Published:
Monday's top analyst upgrades and downgrades included Albermarle, Biogen, Fisker, General Motors, Livent, Marriott International, Uber Technologies and Yelp.
Published:
Last Updated:
Thursday's top analyst upgrades and downgrades included Biogen, Honeywell, Microsoft, Ping Identity, Qualcomm, Verizon Communications and Wendy's.
Published:
Biogen shares rocketed up on Wednesday after briefing documents from the FDA provided evidence of the effectiveness of the firm’s Alzheimer’s disease treatment.
Published:
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.